Related Experiment Video
Updated: Oct 13, 2025
08:22
Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
Published on: July 21, 2013
15.2K
Post COVID-19 cerebral venous sinus thrombosis; a case report
Shwan A Ahmad1, Fahmi H Kakamad1,2,3, Hemin S Mohamad1
1Smart Health Tower, Francios Mettarrand Street, Sulaimani, Kurdistan, Iraq.
Annals of Medicine and Surgery (2012)
|November 15, 2021
Summary
Coronavirus disease 2019 (COVID-19) can be an independent risk factor for cerebral venous sinus thrombosis (CVST). Early diagnosis and anticoagulant treatment are crucial for managing this rare post-COVID-19 complication.
Area of Science:
- Neurology
- Infectious Diseases
- Radiology
Background:
- Cerebral venous sinus thrombosis (CVST) is an uncommon complication associated with coronavirus disease 2019 (COVID-19).
- The incidence and risk factors for post-COVID-19 CVST remain under investigation.
Observation:
- A 58-year-old female with recent severe COVID-19 presented with neurological deficits including hemiparesis and facial palsy.
- Initial laboratory and ultrasound findings were unremarkable.
- Magnetic resonance imaging (MRI) confirmed the diagnosis of CVST.
Findings:
- The patient was treated with anticoagulation, initially with Clexane (enoxaparin) followed by warfarin.
- Significant neurological improvement was observed within weeks, with the patient regaining ambulation.
- Warfarin treatment was successfully discontinued after three months.
Implications:
- Active or recent COVID-19 may be an independent risk factor for CVST, potentially increasing mortality.
- The nonspecific symptoms of CVST necessitate advanced imaging like MRI for diagnosis.
- Optimal anticoagulant choice and treatment duration for post-COVID-19 CVST require further research.
